ReviewChirurgie (Heidelberg, Germany)2026
[When and how are pulmonary metastases surgically treated in sarcomas?]
Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The resection of pulmonary metastases is a local treatment option for sarcomas to achieve complete remission (CR), to histologically obtain metastases and to collect tissue for further molecular pathological investigations. In selected patients with a controlled primary tumor and no evidence of extrathoracic tumor manifestations, a resection of lung metastases can be indicated in a multidisciplinary sarcoma board. The aim is the complete removal of all metastases (R0 resection) with simultaneous preservation of as much healthy lung tissue as possible. Adequate cardiopulmonary fitness for single-lung ventilation and lung resection is mandatory. Minimally invasive techniques, such as video-assisted and robotic-assisted thoracoscopy, which are primarily used for the removal of peripheral metastases adjacent to the pleura as well as an open approach are available for resection. All three procedures have no relevant morbidity and mortality. The evidence is based on retrospective case series demonstrating a survival benefit in selected patients. This article gives an overview of when and how pulmonary metastases should be surgically treated in sarcoma patients.
Indexed as
Identifiers
42747482What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.